Evidence map›Paper›PMID 40539858›Full record

ArticleInternational journal of radiation biology2025

Exploring Auger electron-emitting radionuclides for targeted DNA damage in mismatch repair-deficient cells: a theoretical study of

Alexandre França Velo, Lukas Carter, Michael Bellamy, Mike A Cornejo, Brian M Zeglis, John L Humm

Abstract read
In one paragraph

Article in International journal of radiation biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexandre França VeloDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0001-9786-4136
Lukas CarterDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-4848-4190
Michael BellamyDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-0892-7559
Mike A CornejoDepartment of Chemistry, Hunter College, New York, NY, USA.ORCID 0000-0001-6719-5373
Brian M ZeglisDepartment of Chemistry, Hunter College, New York, NY, USA.ORCID 0000-0002-9091-744X
John L HummDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID 0000-0003-4245-5591

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Targeting DNA Mismatches for Auger Electron RadiotherapyR21CA280595 · NCI · HUNTER COLLEGE · PI HUMM, JOHN L, ZEGLIS, BRIAN MATTHEW · 2023 to 2023
$458k
NCI NIH HHS P30 CA008748NCI NIH HHS R21 CA280595
6 · The paper itself

Abstract

purposePreserving the integrity of the genome is critical to healthy cellular growth and development. Under normal circumstances, the eukaryotic mismatch repair (MMR) machinery is effective at detecting DNA polymerase errors and maintaining the fidelity of the genome. However, cells with inactivated MMR machinery are prone to the accumulation of mutations and tumorigenesis. This study explores the theoretical potential of rhodium-99- and iodine-123-labeled DNA metalloinsertors as Auger electron-emitting radiotherapeutics for cancers characterized by MMR deficiency. MATERIALS AND

methodsA Monte Carlo code was developed in MATLAB

resultsDifferences in the Auger electron emission spectra of

conclusionThis theoretical study leverages both simulation and comparative analyses to identify

Indexed as

Auger electron radiotherapyGeatn4 track codeMetalloinsertorsmismatch repair machineryMonte Carlo simulation

Identifiers

PMID40539858
PMCPMC12314735

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.